Crohn's DiseasePhase 3FORTIFYNCT03105102
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
A Phase 3 study testing Risankizumab IV, Risankizumab SC and Risankizumab On-Body Injector (OBI) in people with Crohn's Disease, run by AbbVie at 496 sites in 47 countries.
Trial summary
The study consists of 4 sub-studies, as follows: Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safety of risankizumab versus placebo as maintenance therapy in participants with moderately to severely active Crohn's disease (CD) who responded to intravenous risankizumab… Read more about this study
- Who is it for?
- Ages 16 to 80 years
- Conditions the study is for
- Crohn's Disease
- What is being tested?
- Risankizumab IV, Risankizumab SC and Risankizumab On-Body Injector (OBI)
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 1,336 participants
- Where
- 496 sitesin 47 countries
- Study dates
- 9 Apr 2018to Feb 2029
- Phase
- Phase 3
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 80 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Participants who have entered and completed Study M16-006 or Study M15-991 or other AbbVie risankizumab Crohn's disease study.
- Participants have completed the study M16-006 or M15-991 and have achieved clinical response.
- Sub-Study 4:
- Participants receiving maintenance treatment in Sub-study 3 and willing to comply with the requirements of Sub-study 4, including self-administration of sub-cutaneous injections using the on-body injector (OBI).
- Participant has received at least 16 weeks of stable dosing with risankizumab in Sub-study 3 (i.e., no rescue within 16 weeks and participant has surpassed the 72-week mark).
Who cannot join
- Participants should not be enrolled in Study M16-000 with high grade colonic dysplasia or colon cancer identified during Study M15-991, Study M16-006 or another AbbVie risankizumab Crohn's disease study if the final endoscopy was performed prior to enter Study M16-000 OR is considered by the Investigator, for any reason, to be an unsuitable candidate for the study.
- Participant who has a known hypersensitivity to risankizumab or the excipients of any of the study drugs or the ingredients of Chinese hamster ovary (CHO), OR had an adverse event (AE) during Studies M16-006, M15-991 or another AbbVie risankizumab Crohn's disease study that in the Investigator's judgment makes the participant unsuitable for this study.
- Participant is not in compliance with prior and concomitant medication requirements throughout Studies M16-006, M15-991 or another AbbVie risankizumab Crohn's disease study.
- Confirmed positive urine pregnancy test at the Final Visit of Study M16-006, Study M15-991 or another AbbVie risankizumab Crohn's disease study.
- Have a known history of lymphoproliferative disease, including lymphoma, or signs and symptoms suggestive of possible lymphoproliferative disease, such as lymphadenopathy and/or splenomegaly.
- Any active or chronic recurring infections based on the Investigator's assessment makes the participant an unsuitable candidate for the study.
Trial locations and contacts
496 sites in 47 countries.
496 sites in 47 countries
United States111 sites
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 157126
Ann Arbor, Michigan, 48109
TX Clinical Research Institute /ID# 159404
Arlington, Texas, 76012
Atlanta Gastro Assoc /ID# 154724
Atlanta, Georgia, 30342
GI Alliance /ID# 161963
Baton Rouge, Louisiana, 70809
Inquest Clinical Research /ID# 165694
Baytown, Texas, 77521-2415
Brandon Premier Health Care, PA/Gulf Coast Research Group, LLC /ID# 162262
Brandon, Florida, 33510-3107
NY Scientific /ID# 158294
Brooklyn, New York, 11235
Saratoga Schenectady Gastroenterology Associates - Burnt Hills /ID# 213447
Burnt Hills, New York, 12027
GI Alliance /ID# 209797
Cedar Park, Texas, 78613
Univ NC Chapel Hill /ID# 154833
Chapel Hill, North Carolina, 27514-4220
Medical University of South Carolina /ID# 212858
Charleston, South Carolina, 29425
Atrium Health Carolinas Medical Center /ID# 158428
Charlotte, North Carolina, 28203
Clin Res Inst of Michigan, LLC /ID# 169179
Chesterfield, Michigan, 48047
Metropolitan Gastroenterology Group - Chevy Chase /ID# 154832
Chevy Chase, Maryland, 20815
Duplicate_Northwestern University /ID# 158261
Chicago, Illinois, 60611-2927
The University of Chicago Medical Center /ID# 157124
Chicago, Illinois, 60637-1443
Tri-State Endoscopy Center /ID# 154927
Cincinnati, Ohio, 45219
South Lake Pain Institute, Inc /ID# 162808
Clermont, Florida, 34711
Cleveland Clinic Main Campus /ID# 209226
Cleveland, Ohio, 44195
Peak Gastroenterology Associates, PC /ID# 165843
Colorado Springs, Colorado, 80907
Gastro Center of Maryland /ID# 165001
Columbia, Maryland, 21045
The Ohio State University /ID# 164708
Columbus, Ohio, 43210
Optimed Research, Ltd. /ID# 167887
Columbus, Ohio, 43235
Gastro One /ID# 154726
Cordova, Tennessee, 38018
Southern California Res. Ctr. /ID# 211991
Coronado, California, 92118-1408
Baylor Scott & White Center for Inflammatory Bowel Diseases /ID# 159406
Dallas, Texas, 75246
Duplicate_Western Connecticut Medical Group /ID# 165879
Danbury, Connecticut, 06810
Hometown Urgent Care and Resea /ID# 170464
Dayton, Ohio, 45424
Universal Axon Clinical Research /ID# 165428
Doral, Florida, 33166
NorthShore University-Endeavor Health Evanston Hospital /ID# 158265
Evanston, Illinois, 60201
Plains Clinical Research Center, LLC /ID# 169718
Fargo, North Dakota, 58104-5925
Intercity Advanced Gastroentertology Center /ID# 215205
Fresh Meadows, New York, 11366
Duplicate_DHAT Research Institute /ID# 158208
Garland, Texas, 75044-2208
Northwell Health - Great Neck /ID# 168738
Great Neck, New York, 11021
Gastroenterology Associates, P.A. of Greenville /ID# 154904
Greenville, South Carolina, 29607
Houma Digestive Health Special /ID# 158264
Houma, Louisiana, 70360
Vilo Research Group Inc /ID# 207655
Houston, Texas, 77017-2337
Baylor College of Medicine /ID# 158203
Houston, Texas, 77030
Centex Studies, Inc. - Houston /ID# 201219
Houston, Texas, 77058
Duplicate_Newport Huntington Medical Group /ID# 213035
Huntington Beach, California, 92648
Nature Coast Clinical Research - Inverness /ID# 159408
Inverness, Florida, 34452-4717
East Tennessee Research Institute /ID# 168739
Johnson City, Tennessee, 37604
SIH Research Mumtaz, Inc /ID# 163083
Kissimmee, Florida, 34741-4161
UC San Diego Health Systems /ID# 155555
La Jolla, California, 92093
Nyu Langone Long Island Clinical Research Associates - Lake Success /ID# 154829
Lake Success, New York, 11042
Revival Research Institute - Las Vegas /ID# 210985
Las Vegas, Nevada, 89128-3157
Vector Clinical Trials /ID# 160170
Las Vegas, Nevada, 89128
Duplicate_University of Kentucky Chandler Medical Center /ID# 157120
Lexington, Kentucky, 40536
Alliance Medical Research /ID# 163837
Lighthouse PT, Florida, 33064
Atria Clinical Research /ID# 164505
Little Rock, Arkansas, 72209-7040
Rocky Mountain Pediatric Gastroenterology /ID# 207170
Lone Tree, Colorado, 80124-6798
United Medical Doctors /ID# 207888
Los Alamitos, California, 90720-3309
TLC Clinical Research Inc /ID# 212719
Los Angeles, California, 90048
Gastrointestinal Biosciences Clinical Trials /ID# 162657
Los Angeles, California, 90067-2001
University of Louisville Hospital /ID# 210525
Louisville, Kentucky, 40202
Gastroenterology Associates of Central Georgia, LLC /ID# 154850
Macon, Georgia, 31201
Cfagi Llc /Id# 202479
Maitland, Florida, 32751-6108
Clinical Neuroscience Solutions /ID# 164180
Memphis, Tennessee, 38119
Great Lakes Gastroenterology Research, LLC /ID# 201770
Mentor, Ohio, 44060-6211
Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211884
Mesa, Arizona, 85206
Sylvester Comprehensive Cancer Center /ID# 155007
Miami, Florida, 33136-1002
Coral Research Clinic /ID# 158456
Miami, Florida, 33186-4643
South Florida Research Ph I-IV, Inc. /ID# 161832
Miami, Florida, 33193
West Virginia University Hospitals /ID# 167941
Morgantown, West Virginia, 26506
United Medical Doctors - Murrieta /ID# 158300
Murrieta, California, 92563
Gastroenterology Group Naples /ID# 165204
Naples, Florida, 34102
Vanderbilt University Medical Center /ID# 157121
Nashville, Tennessee, 37232-0011
Digestive Disease Care /ID# 211777
New Hyde Park, New York, 11040
Delricht Research - Prytania Street - New Orleans /ID# 206644
New Orleans, Louisiana, 70115
Nola Research Works, LLC /ID# 161317
New Orleans, Louisiana, 70115
Advanced Research Institute, Inc /ID# 161966
New Port Richey, Florida, 34653
NYU Langone Medical Center /ID# 160169
New York, New York, 10016-6402
Weill Cornell Medicine /ID# 165878
New York, New York, 10022
Icahn School of Medicine at Mount Sinai /ID# 165612
New York, New York, 10029
Columbia Univ Medical Center /ID# 161899
New York, New York, 10032-3725
Lenox Hill Hospital /ID# 168467
New York, New York, 10075
Duplicate_DiGiovanna Institute for Medical Education & Research /ID# 171126
North Massapequa, New York, 11758
Southwest Gastroenterology /ID# 164781
Oak Lawn, Illinois, 60453
Advanced Research Institute /ID# 154907
Ogden, Utah, 84405
Hightower Clinical /ID# 211993
Oklahoma City, Oklahoma, 73102
Digestive Disease Specialists /ID# 170775
Oklahoma City, Oklahoma, 73112
University of Nebraska Medical Center /ID# 210058
Omaha, Nebraska, 68198-2000
Endoscopic Research, Inc. /ID# 205906
Orlando, Florida, 32803
Omega Research - Orlando /ID# 171082
Orlando, Florida, 32808
IMIC Inc. Medical Research /ID# 154942
Palmetto Bay, Florida, 33157
Phoenix VA Health Care System /ID# 162264
Phoenix, Arizona, 85012
Children's Hospital of Pittsburgh of UPMC /ID# 212544
Pittsburgh, Pennsylvania, 15224-1334
Wake Radiology UNC REX Healthcare - Raleigh Office /ID# 154873
Raleigh, North Carolina, 27612
Rapid City Medical Center - GI Research /ID# 163838
Rapid City, South Dakota, 57701
Richmond VA Medical Center /ID# 159988
Richmond, Virginia, 23249
Mayo Clinic - Rochester /ID# 163086
Rochester, Minnesota, 55905-0001
Clinical Associates in Research Therapeutics of America, LLC /ID# 161323
San Antonio, Texas, 78212
Southern Star Research Institute, LLC /ID# 168773
San Antonio, Texas, 78229-5390
University of California San Francisco - Mission Bay /ID# 157127
San Francisco, California, 94158
Duplicate_Virginia Mason Medical Center /ID# 155556
Seattle, Washington, 98101
Louisiana Research Center, LLC /ID# 162237
Shreveport, Louisiana, 71105-6800
St. Louis University /ID# 161883
St Louis, Missouri, 63104
Duplicate_Clinical Research of West Florida, Inc /ID# 208125
Tampa, Florida, 33606-1246
Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 205865
Tampa, Florida, 33606
Baylor Scott & White Center for Diagnostic Medicine /ID# 204131
Temple, Texas, 76508
Cotton O'Neil Clinical Research Center, Digestive Health /ID# 154722
Topeka, Kansas, 66606
Center For Digestive Health - Troy /ID# 154683
Troy, Michigan, 48098
Banner - University Medical Center Tucson /ID# 158502
Tucson, Arizona, 85719
Adult Gastroenterology Associates - Gen 1 Research /ID# 208864
Tulsa, Oklahoma, 74136-7823
Tyler Research Institute /ID# 166797
Tyler, Texas, 75701
Gastro Health & Nutrition - Victoria /ID# 164290
Victoria, Texas, 77904
Texas Digestive Disease Consultants /ID# 209946
Webster, Texas, 77598
Duplicate_Cedars-Sinai Medical Center-West Hollywood /ID# 163839
West Hollywood, California, 90048
Velocity Clinical Research - Salt Lake City /ID# 161778
West Jordan, Utah, 84088
Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinic /ID# 161313
Wyoming, Michigan, 49519
Digestive Disease Associates, LTD - Wyomissing /ID# 208297
Wyomissing, Pennsylvania, 19610
Japan45 sites
Tokatsu Tsujinaka Hospital /ID# 163352
Abiko-shi, Chiba, 270-1168
Duplicate_Asahikawa Medical University Hospital /ID# 162848
Asahikawa-shi, Hokkaido, 078-8510
Institute of Science Tokyo Hospital /ID# 160095
Bunkyo-ku, Tokyo, 113-8519
Duplicate_Chiba University Hospital /ID# 217533
Chiba, Chiba, 260-8677
Fukuoka University Hospital /ID# 217793
Fukuoka, Fukuoka, 814-0180
National Hospital Organization Fukuyama Medical Center /ID# 163577
Fukuyama-shi, Hiroshima, 720-8520
Tokai University Hachioji Hospital /ID# 160098
Hachioji-shi, Tokyo, 192-0032
Hamamatsu University Hospital /ID# 205690
Hamamatsu, Shizuoka, 431-3192
NHO Mito Medical Center /ID# 160092
Higashiibaraki-gun, Ibaraki, 311-3193
Hiroshima University Hospital /ID# 160109
Hiroshima, Hiroshima, 734-8551
Gokeikai Ofuna Chuo Hospital /ID# 171066
Kamakura-shi, Kanagawa, 247-0056
Kanazawa University Hospital /ID# 202258
Kanazawa, Ishikawa-ken, 920-8641
Tsujinaka Hospital - Kashiwanoha /ID# 213848
Kashiwa-shi, Chiba, 277-0871
The Jikei University Kashiwa Hospital /ID# 200030
Kashiwa-shi, Chiba, 277-8567
Saitama Medical Center /ID# 160093
Kawagoe, Saitama, 350-8550
Yamanashi Prefectural Central Hospital /ID# 160094
Kofu, Yamanashi, 400-8506
Kurume University Hospital /ID# 160106
Kurume-shi, Fukuoka, 830-0011
Duplicate_The Jikei University Hospital /ID# 163209
Minato-ku, Tokyo, 105-8471
Kitasato University Kitasato Institute Hospital /ID# 160105
Minato-ku, Tokyo, 108-8642
Kyorin University Hospital /ID# 160114
Mitaka-shi, Tokyo, 181-8611
Aichi Medical University Hospital /ID# 160097
Nagakute, Aichi-ken, 480-1195
Daido Clinic - Nagoya /ID# 211476
Nagoya, Aichi-ken, 457-8511
Nagoya University Hospital /ID# 160116
Nagoya, Aichi-ken, 466-8560
Nagoya City University Hospital /ID# 160100
Nagoya, Aichi-ken, 467-8602
Nishinomiya Municipal Central Hospital /ID# 210103
Nishinomiya-shi, Hyōgo, 663-8014
Hyogo Medical University Hospital /ID# 160107
Nishinomiya-shi, Hyōgo, 663-8501
Osaka Metropolitan University Hospital /ID# 160117
Osaka, Osaka, 545-8586
Shiga University of Medical Science Hospital /ID# 164025
Ōtsu, Shiga, 520-2192
Kitasato University Hospital /ID# 171065
Sagamihara-shi, Kanagawa, 252-0375
Tokitokai Tokito clinic /ID# 160110
Saitama-shi, Saitama, 336-0963
Toho University Sakura Medical Center /ID# 160099
Sakura-shi, Chiba, 285-8741
Sapporo Tokushukai Hospital /ID# 213492
Sapporo, Hokkaido, 004-0041
Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 160096
Sapporo, Hokkaido, 060-0033
Sapporo Medical University Hospital /ID# 163056
Sapporo, Hokkaido, 060-8543
Tohoku University Hospital /ID# 162847
Sendai, Miyagi, 9808574
Tohoku Rosai Hospital /ID# 163229
Sendai, Miyagi, 981-8563
Tokyo Women's Medical University Hospital /ID# 205974
Shinjuku-ku, Tokyo, 162-8666
NHO Shizuoka Medical Center /ID# 163057
Sunto-gun, Shizuoka, 411-8611
Duplicate_Fujita Health University Hospital /ID# 163234
Toyoake-shi, Aichi-ken, 470-1192
Mie University Hospital /ID# 203640
Tsu, Mie-ken, 514-8507
Wakayama Medical University Hospital /ID# 202561
Wakayama, Wakayama, 641-8510
Yamagata University Hospital /ID# 200159
Yamagata, Yamagata, 990-9585
Yokkaichi Hazu Medical Center /ID# 163764
Yokkaichi-shi, Mie-ken, 510-0016
Duplicate_Yokohama Municipal Citizen's Hospital /ID# 207161
Yokohama, Kanagawa, 221-0855
Duplicate_Yokohama City University Medical Center /ID# 163907
Yokohama, Kanagawa, 232-0024
Germany28 sites
Duplicate_Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 212220
Berlin, 10117
Dr. med. Thomas Brunk Gastroenterology Berlin /ID# 211974
Berlin, 10318
MVZ fuer Gastroenterlogie am Bayerischen Platz /ID# 159350
Berlin, 10825
Charite Universitaetsmedizin Berlin Campus Virchow-Klinikum /ID# 212894
Berlin, 13353
DRK Kliniken Berlin Westend /ID# 166151
Berlin, 14050
Krankenhaus Waldfriede /ID# 212727
Berlin-Zehlendorf, 14163
Stadtisches Klinikum Braunschweig /ID# 163680
Braunschweig, 38126
Universitaetsklinikum Koeln /ID# 164989
Cologne, North Rhine-Westphalia, 50937
Evangelisches Krankenhaus Kalk /ID# 212726
Cologne, North Rhine-Westphalia, 51103
Medizinisches Versorgunszentrum Dachau /ID# 211555
Dachau, Bavaria, 85221
Universitaetsklinikum Erlangen /ID# 159343
Erlangen, Bavaria, 91054
Duplicate_Agaplesion Markus Krankenhaus /ID# 159345
Frankfurt am Main, Hesse, 60431
Universitaetsklinikum Frankfurt /ID# 212979
Frankfurt am Main, Hesse, 60590
Universitaetsklinikum Freiburg /ID# 162030
Freiburg im Breisgau, Baden-Wurttemberg, 79106
Praxiszentrum fuer Gastroenterologie /ID# 211966
Grevenbroich, North Rhine-Westphalia, 41515
Medizinische Hochschule Hannover /ID# 162032
Hanover, Lower Saxony, 30625
Praxis fuer Gastroenterologie - Heidelberg /ID# 166150
Heidelberg, Baden-Wurttemberg, 69121
Universitaetsklinikum Jena /ID# 159351
Jena, Thuringia, 07747
Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 159349
Kiel, Schleswig-Holstein, 24105
Eugastro /ID# 212078
Leipzig, Saxony, 04103
Klinikum Lueneburg /ID# 163678
Lüneburg, Lower Saxony, 21339
Universitaetsklinikum Magdeburg /ID# 211843
Magdeburg, 39120
Universitatsklinikum Mannheim /ID# 162031
Mannheim, Baden-Wurttemberg, 68167
Gastroenterologische Gemeinschaftspraxis Minden /ID# 162029
Minden, North Rhine-Westphalia, 32423
Universitaetsklinikum Muenster - Albert Schweitzer Campus /ID# 159344
Münster, North Rhine-Westphalia, 48149
Universitaetsklinikum Regensburg /ID# 163813
Regensburg, Bavaria, 93042
Zentrum für Gastroenterologie Saar MVZ GmbH /ID# 210528
Saarbrücken, Saarland, 66111
Universitaetsklinikum Ulm /ID# 164990
Ulm, Baden-Wurttemberg, 89081
Canada19 sites
University of Calgary /ID# 157155
Calgary, Alberta, T2N 4Z6
Allen Whey Khye Lim Professional Corporation /ID# 169763
Edmonton, Alberta, T5R 1W2
University of Alberta Hospital /ID# 157099
Edmonton, Alberta, T6G 2B7
Covenant Health /ID# 161632
Edmonton, Alberta, T6K 4B2
Medicor Research Inc /ID# 157150
Greater Sudbury, Ontario, P3A 1W8
CISSS de la Monteregie Centre - Hopital Charles Le Moyne /ID# 161630
Greenfield Park, J4V 2H1
Queen Elizabeth II Health Sciences Centre - Victoria General /ID# 157088
Halifax, Nova Scotia, B3H 2Y9
IWK Health Center /ID# 165905
Halifax, Nova Scotia, B3K 6R8
Duplicate_Hamilton Health Sciences -McMaster University Medical Centre /ID# 157184
Hamilton, Ontario, L8S 4K1
Hotel Dieu de Levis /ID# 214377
Lévis, Quebec, G6V 3Z1
London Health Sciences Center- University Hospital /ID# 157161
London, Ontario, N6A 5W9
CIUSSS de l'est de l'Ile-de-Montreal - Hopital Maisonneuve-Rosemont /ID# 159056
Montreal, Quebec, H1T 2M4
Montreal General Hospital- McGill University Health Center /ID# 157085
Montreal, Quebec, H3G 1A4
Fraser Clinical Trials Inc /ID# 159055
New Westminster, British Columbia, V3L 3W4
Scott Shulman Medicine Professional Corporation /ID# 165906
North Bay, Ontario, P1B 2H3
Mount Sinai Hospital /ID# 169764
Toronto, Ontario, M5G 1X5
Giri Gi Research Institute - Vancouver /ID# 157096
Vancouver, British Columbia, V5Z 2K5
Toronto Digestive Disease Associates /ID# 157158
Vaughan, Ontario, L4L 4Y7
Percuro Clinical Research, Ltd /ID# 161631
Victoria, British Columbia, V8V 3M9
Italy19 sites
IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 155643
Bologna, 40138
Ospedale Cannizzaro /ID# 161300
Catania, 95126
Azienda Ospedaliero-Universitaria Renato Dulbecco /ID# 212016
Catanzaro, 88100
Duplicate_Azienda Ospedaliera Univ. Meyer /ID# 167992
Florence, Tuscany, 50139
Duplicate_Ospedale Policlinico San Martino /ID# 162439
Genoa, Genova, 16132
ASST Fatebenefratelli Sacco /ID# 155639
Milan, Milano, 20157
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 155641
Milan, 20122
Duplicate_Azienda Ospedaliero-Universitaria Policlinico di Modena /ID# 212028
Modena, 41124
IRCCS Ospedale Sacro Cuore Don Calabria /ID# 161299
Negrar, Verona, 37024
Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello /ID# 155645
Palermo, 90146
Duplicate_Fondazione IRCCS Policlinico S. Matteo /ID# 212031
Pavia, 27100
ASST Rhodense/Presidio Ospedaliero di Rho /ID# 212227
Rho, Milano, 20017
Duplicate_Fondazione Policlinico Universitario Campus Bio-Medico di Roma /ID# 162438
Rome, Roma, 00128
Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 158022
Rome, Roma, 00133
Azienda Ospedaliera San Camillo Forlanini /ID# 155644
Rome, Roma, 00149
Duplicate_Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 166912
Rome, Roma, 00161
Presidio Columbus-Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Un /ID# 155640
Rome, Roma, 00168
IRCCS Istituto Clinico Humanitas /ID# 155642
Rozzano, Lombardy, 20089
Duplicate_AOU Ospendali Riuniti di Ancona /ID# 162436
Torrette, Ancona, 60123
China16 sites
The Second Xiangya Hospital Of Central South University /ID# 211700
Changsha, Hunan, 410011
West China Hospital, Sichuan University /ID# 210890
Chengdu, Sichuan, 610041
Guangdong Provincial Peoples Hospital /ID# 212949
Guangzhou, Guangdong, 510080
The Sixth Affiliated Hospital of Sun Yat-sen University /ID# 210784
Guangzhou, Guangdong, 510655
The Second Affiliated Hospital of Zhejiang University School of Medicine /ID# 210724
Hangzhou, Zhejiang, 310009
Sir Run Run Shaw Hospital Zhejiang University School of Medicine /ID# 210625
Hangzhou, Zhejiang, 310020
Jinhua Municipal Central Hospital /ID# 215628
Jinhua, Zhejiang, 321000
The First Affiliated Hospital of Nanchang University /ID# 211036
Nanchang, Jiangxi, 330006
Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 210840
Shanghai, Shanghai Municipality, 200065
Renji Hospital, Shanghai Jiaotong University School of Medicine /ID# 210705
Shanghai, Shanghai Municipality, 200127
Shanghai East Hospital /ID# 212684
Shanghai, Shanghai Municipality, 200136
The Second Hospital of Hebei Medical University /ID# 212738
Shijiazhuang, Hebei, 050000
Tianjin Medical University General Hospital /ID# 210926
Tianjin, Tianjin Municipality, 300052
Duplicate_Union Hospital Tongji Medical College Huazhong University of Science a /ID# 211039
Wuhan, Hubei, 430022
Tongji Hospital Tongji Medical College of HUST /ID# 210858
Wuhan, Hubei, 430030
Renmin Hospital of Wuhan University /ID# 214874
Wuhan, Hubei, 430060
United Kingdom16 sites
Barnsley Hospital NHS Foundation Trust /ID# 202773
Barnsley, South Yorkshire, S75 2EP
University Hospitals Birmingham NHS Foundation Trust /ID# 157545
Birmingham, B15 2TH
Addenbrookes Hospital /ID# 158034
Cambridge, Cambridgeshire, CB2 2QQ
Ashford and St Peter's Hospitals NHS Foundation Trust /ID# 207936
Chertsey, Surrey, KT16 0PZ
Western General Hospital /ID# 207448
Edinburgh, Edinburgh, City of, EH4 2XU
Duplicate_Royal Devon University Healthcare NHS Foundation Trust /ID# 157544
Exeter, Devon, EX2 5DW
Gartnavel General Hospital /ID# 202568
Glasgow, Glasgow City, G12 0YN
Calderdale and Huddersfield NHS Foundation Trust /ID# 209570
Huddersfield, HX3 0PW
Hull University Teaching Hospitals NHS Trust /ID# 158761
Hull, East Riding Of Yorkshire, HU3 2JZ
Leeds Teaching Hospitals NHS Trust /ID# 157550
Leeds, West Yorkshire, LS9 7TF
Disc_Barts Health NHS Trust - The Royal London Hospital /ID# 163713
London, Greater London, E1 2ES
Dup_Guys and St Thomas NHS Foundation Trust - Guy's Hospital /ID# 157546
London, Greater London, SE1 9RT
Kings College Hospital NHS Foundation Trust /ID# 158760
London, Greater London, SE5 9RS
Fairfield General Hospital /ID# 207766
Manchester, Lancashire, BL9 7TD
The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 163708
Newcastle upon Tyne, NE3 3HD
Oxford University Hospitals NHS Foundation Trust /ID# 158036
Oxford, Oxfordshire, OX3 9DU
Poland15 sites
Centrum Medyczne Lukamed Sp. z o.o. /ID# 212478
Chojnice, Pomeranian Voivodeship, 89-600
Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego w Lodzi /ID# 212477
Lodz, Łódź Voivodeship, 90-153
1 Wojskowy Szpital Kliniczny Z Poliklinika /Id# 210940
Lublin, Lublin Voivodeship, 20-049
Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie /ID# 210941
Lublin, Lublin Voivodeship, 20-090
Wojewodzki Szpital Specjalistyczny W Olsztynie /ID# 212474
Olsztyn, Warmian-Masurian Voivodeship, 10-561
Solumed Centrum Medyczne /ID# 163569
Poznan, Greater Poland Voivodeship, 60-529
Centrum Medycznym Medyk /ID# 212891
Rzeszów, Podkarpackie Voivodeship, 35-055
Gastromed Sp. z o.o /ID# 212476
Torun, Kuyavian-Pomeranian Voivodeship, 87-100
H-T Centrum Medyczne Endoterapia /ID# 212475
Tychy, Silesian Voivodeship, 43-100
Centrum Zdrowia MDM /ID# 163570
Warsaw, Masovian Voivodeship, 00-189
Panstwowy Instytut Medyczny MSWiA w Warszawie /ID# 163582
Warsaw, Masovian Voivodeship, 02-507
Vivamed Sp. z o.o. /ID# 202800
Warsaw, Masovian Voivodeship, 03-580
Instytut Pomnik - Centrum Zdrowia Dziecka /ID# 213580
Warsaw, Masovian Voivodeship, 04-730
Duplicate_Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocl /ID# 212601
Wroclaw, Lower Silesian Voivodeship, 50-556
Planetmed Sp. z o.o. /ID# 202799
Wroclaw, Lower Silesian Voivodeship, 52-210
Spain14 sites
Hospital Clinic de Barcelona /ID# 157552
Barcelona, 08036
Hospital Universitario Basurto /ID# 205190
Bilbao, Vizcaya, 48013
Hospital Arquitecto Marcide - Complejo Hospitalario Universitario de Ferrol /ID# 157553
Ferrol, A Coruna, 15405
Hospital Universitari de Bellvitge /ID# 208207
L'Hospitalet de Llobregat, Barcelona, 08907
Hospital General Universitario Gregorio Maranon /ID# 161145
Madrid, 28007
Hospital Universitario La Paz /ID# 159235
Madrid, 28046
Hospital Universitario Puerta de Hierro - Majadahonda /ID# 157573
Majadahonda, Madrid, 28222
Consorci Corporacio Sanitaria Parc Tauli Sabadell /ID# 159237
Sabadell, Barcelona, 08208
Hospital Universitario de Salamanca /ID# 157558
Salamanca, 37711
Hospital Universitario Virgen Macarena /ID# 159967
Seville, 41009
Hospital Clinico Universitario de Valencia /ID# 209700
Valencia, 46010
Hospital Universitario y Politecnico La Fe /ID# 157556
Valencia, 46026
Hospital Clinico Universitario Lozano Blesa /ID# 212525
Zaragoza, 50009
Hospital Universitario Miguel Servet /ID# 157557
Zaragoza, 50009
Belgium13 sites
Universite Libre de Bruxelles - Hopital Erasme /ID# 157408
Anderlecht, Brussels Capital, 1070
Imelda Ziekenhuis /ID# 157403
Bonheiden, Antwerpen, 2820
Cliniques Universitaires UCL Saint-Luc /ID# 157406
Brussels, Brussels Capital, 1200
UZ Gent /ID# 157405
Ghent, Oost-Vlaanderen, 9000
AZ Maria Middelares /ID# 213532
Ghent, 9000
AZ Groeninge /ID# 211513
Kortrijk, 8500
Universitair Ziekenhuis Leuven /ID# 157407
Leuven, Vlaams-Brabant, 3000
Groupe Sante CHC - Clinique du MontLegia /ID# 157404
Liège, Liege, 4000
CHU de Liege /ID# 157409
Liège, 4000
AZ Sint-Maarten /ID# 212876
Mechelen, Antwerpen, 2800
ZAS Palfijn /ID# 212877
Merksem, Antwerpen, 2170
AZ-Delta. /ID# 157402
Roeselare, West-Vlaanderen, 8800
Universite Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant /ID# 157412
Yvoir, Namur, 5530
France12 sites
CHU Amiens-Picardie Site Sud /ID# 165058
Amiens, Somme, 80054
Hopital Beaujon /ID# 166284
Clichy, Île-de-France Region, 92110
Duplicate_CHU Grenoble - Hopital Michallon /ID# 212834
La Tronche, Isere, 38700
CHRU Lille - Hopital Claude Huriez /ID# 162559
Lille, Nord, 59037
CHU Montpellier - Hopital Saint Eloi /ID# 215147
Montpellier, Herault, 34295
Centre Medico Chirurgical Ambroise Pare Hartmann /ID# 249858
Neuilly-sur-Seine, Île-de-France Region, 92200
Chu de Nice-Hopital Larchet Ii /Id# 162557
Nice, Alpes-Maritimes, 06202
Centre Hospitalier Universitaire de Bordeaux /ID# 162558
Pessac, New Aquitaine, 33604
HCL - Hopital Lyon Sud /ID# 162560
Pierre-Bénite, Rhone, 69495
CHRU Pontchaillou /ID# 213209
Rennes, 35033
Centre Hospitalier Universitaire de Saint Etienne - Hopital Nord /ID# 162562
St-Priest-en-Jarez, Pays de la Loire Region, 42270
Centre Hospitalier Regional Universitaire de Nancy - Hopitaux de Brabois /ID# 162561
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, 54511
South Korea12 sites
Inje University Haeundae Hospital /ID# 202518
Busan, Busan Gwang Yeogsi, 48108
Dong-A University Medical Center /ID# 158699
Busan, Busan Gwang Yeogsi, 49201
Pusan National University Hospital /ID# 158695
Busan, Busan Gwang Yeogsi, 49241
Yeungnam University Medical Center - Daegu /ID# 158691
Daegu, Daegu Gwang Yeogsi, 42415
The Catholic University of Korea, Daejeon St. Mary's Hospital /ID# 213554
Daejeon, Daejeon Gwang Yeogsi, 34943
Hanyang University Guri Hospital /ID# 158690
Guri-si, Gyeonggido, 11923
Duplicate_CHA University Bundang Medical Center /ID# 158698
Seongnam-si, Gyeonggido, 13496
Kangbuk Samsung Hospital /ID# 158694
Seoul, Seoul Teugbyeolsi, 03181
Asan Medical Center /ID# 158696
Seoul, Seoul Teugbyeolsi, 05505
Samsung Medical Center /ID# 158692
Seoul, Seoul Teugbyeolsi, 06351
Yonsei University Health System Severance Hospital /ID# 158689
Seoul, 03722
The Catholic University Of Korea St. Vincent's Hospital /ID# 158693
Suwon, Gyeonggido, 16247
Ukraine12 sites
Kharkiv City Clinical Hospital No.2 n.a. Prof. O.O. Shalimov /ID# 165657
Kharkiv, 61037
Municipal Nonprofit Enterprise Kherson city clinical hospital n.a. Y.Y. Karabel /ID# 212399
Kherson, 73000
Kyiv City Clinical Hospital No.18 /ID# 162531
Kyiv, 01030
Medical Center OK Clinic LLC, International Institute of Clinical Research /ID# 211998
Kyiv, 02091
Communal Noncommercial Institution Consultative and Diagnostic Center of Desnian /ID# 165659
Kyiv, 02232
Medical Center of LLC Medbud-Clinic /ID# 216998
Kyiv, 03037
Kyiv Railway Clinical Hosp No.2 /ID# 217366
Kyiv, 03049
ME Volyn Regional Clinical Hospital of Volyn Regional Council /ID# 206789
Lutsk, Volyn Oblast, 43005
Lviv Railway Clinical Hospital of branch Healthcare Centers of Public Joint Stoc /ID# 165658
Lviv, Lviv Oblast, 79000
Transcarpathian Regional Clinical Hospital n.a. Andriy Novak /ID# 167960
Uzhhorod, Zakarpattia Oblast, 88018
Centre of Gastroenterology and Dietetics /ID# 216474
Vinnytsia, Vinnytsia Oblast, 21018
University Hospital of M.I. Pyrogov VNMU /ID# 212000
Vinnytsia, Vinnytsia Oblast, 21029
Portugal11 sites
Duplicate_Hospital Garcia de Orta, EPE /ID# 160745
Almada, Setúbal District, 2805-267
Centro Hospitalar Universitário do Algarve, EPE - Hospital Faro /ID# 160713
Faro, 8000-386
Duplicate_Hospital da Senhora da Oliveira Guimaraes, EPE /ID# 160737
Guimarães, Braga District, 4835-044
Centro Hospitalar de Lisboa Central - Lisbon /ID# 160673
Lisbon, Lisbon District, 1169-050
Centro Hospitalar De Lisboa Ocidental - Hospital De Egas Moniz /ID# 167751
Lisbon, Lisbon District, 1349-019
Unidade Local de Saude de Santa Maria /ID# 160692
Lisbon, 1649-035
Hospital de Loures, E.P.E /ID# 207759
Loures, 2674-514
Centro Hospitalar Universitário do Algarve, EPE - Hospital de Portimão /ID# 167752
Portimão, Faro District, 8500-338
Unidade Local de Saude Sao Joao /ID# 160693
Porto, 4200-319
Centro Hospitalar de Entre Douro e Vouga /ID# 160672
Santa Maria DA Feira, Porto District, 4520-211
Centro Hosp de Tondela-Viseu /ID# 160699
Viseu, 3504-509
Russia11 sites
Alliance Biomedical Ural Group /ID# 200972
Izhevsk, Udmurtiya Republic, 426061
Kuzbass Regional Clinical Hospital /ID# 200962
Kemerovo, Kemerovo Oblast, 650099
National Medical Research Center of Coloproctology n.a. A. N. Ryzhikh /ID# 204808
Moscow, 123423
Novosibirski Gastrocenter /ID# 217552
Novosibirsk, Novosibirsk Oblast, 630007
Duplicate_Perm state medical university n.a. E.A. Vagner /ID# 207439
Perm, Permskiy Kray, 614990
Duplicate_St. Petersburg State Pediatric Medical University /ID# 211978
Saint Petersburg, Sankt-Peterburg, 194100
City Clinical Hospital No. 31 /ID# 208872
Saint Petersburg, 197110
Professor Pasechnikov Gastroenterology and Pankreatology clinic /ID# 200970
Stavropol, Stavropol Kray, 355012
Tver Regional Clinical Hospital /ID# 206858
Tver', Tver Oblast, 170036
Regional Clinical Hospital #1 /ID# 200973
Tyumen, Tyumen Oblast, 625023
Ulyanovsk Regional Clinical Hospital /ID# 200964
Ulyanovsk, 432017
Czechia9 sites
Hepato-Gastroenterologie HK, s.r.o. /ID# 163225
Hradec Králové, 500 12
Nemocnice Pardubickeho kraje, a.s. /ID# 163226
Pardubice, 530 03
Duplicate_Institut klinicke a experimentalni mediciny (IKEM) /ID# 165465
Prague, Praha 4, 140 00
ResTrial GastroEndo /ID# 211078
Prague, Praha 4, 143 00
Iscare Klinicke Centrum /ID# 225794
Prague, Praha 9, 190 00
Nemocnice Milosrdnych sester sv. Karla Boromejskeho v Praze /ID# 211306
Prague, 118 33
Axon Clinical, s.r.o. /ID# 163223
Prague, 140 00
Fakultni Thomayerova nemocnice /ID# 162941
Prague, 140 59
Nemocnice Horovice - NH Hospital a.s /ID# 211077
Prague, 155 00
Israel9 sites
Soroka University Medical Center /ID# 157794
Beersheba, Southern District, 8443901
Duplicate_Rambam Medical Center /ID# 171067
Haifa, 3109601
The Edith Wolfson Medical Center /ID# 217331
Holon, Southern District, 5822000
Shaare Zedek Medical Center /ID# 163541
Jerusalem, Jerusalem, 91031
Shaare Zedek Medical Center /ID# 171068
Jerusalem, Jerusalem, 91031
Hadassah Medical Center-Hebrew University /ID# 165914
Jerusalem, Jerusalem, 91120
The Chaim Sheba Medical Center /ID# 157793
Ramat Gan, Tel Aviv, 5265601
The Chaim Sheba Medical Center /ID# 171069
Ramat Gan, Tel Aviv, 5265601
Tel Aviv Sourasky Medical Center /ID# 157792
Tel Aviv, Tel Aviv, 6423906
Serbia9 sites
Clinical Hosp Center Zvezdara /ID# 157052
Belgrade, Beograd, 11000
Military Medical Academy /ID# 157053
Belgrade, Beograd, 11000
University Children's Hospital 'Tirsova' /ID# 211482
Belgrade, Beograd, 11000
University Clinical Center Serbia /ID# 157047
Belgrade, Beograd, 11000
Clinical Hospital Center Dr Dragisa Misovic - Dedinje /ID# 212799
Belgrade, Beograd, 11040
Clin Hosp Ctr Bezanijska Kosa /ID# 157050
Belgrade, Beograd, 11080
Duplicate_University Clinical Center Kragujevac /ID# 157049
Kragujevac, Sumadijski Okrug, 34000
General Hospital Leskovac /ID# 209575
Leskovac, Jablanicki Okrug, 16000
University Clinical Center Vojvodina /ID# 157046
Novi Sad, 21000
Bulgaria7 sites
UMHAT Dr Georgi Stranski EAD /ID# 203976
Pleven, 5800
Umbal Kaspela /ID# 165700
Plovdiv, 4001
2nd Mhat /ID# 165702
Sofia, 1202
Tokuda Hospital Sofia /ID# 165701
Sofia, 1407
UMHAT Sveti Ivan Rilski /ID# 204815
Sofia, 1431
Duplicate_UMHAT Tsaritsa Joanna - ISUL /ID# 211242
Sofia, 1527
MHAT Trakia /ID# 201668
Stara Zagora, 6004
Greece7 sites
General Hospital of Chest Diseases of Athens SOTIRIA /ID# 170914
Athens, Attica, 11527
General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 157423
Athens, 10676
University General Hospital of Heraklion PA.G.N.I /ID# 157422
Heraklion, Crete, 71500
University General Hospital of Ioannina /ID# 157420
Ioannina, 45500
General Hospital of Nikaia-Piraeus "Agios Panteleimon" /ID# 157424
Nikaia, Attica, 18454
Tzaneio general hospital of Piraeus /ID# 206443
Piraeus, Attica, 18536
Theageneio Anticancer Hospital /ID# 163897
Thessaloniki, 54639
Sweden7 sites
Duplicate_Sahlgrenska University Hospital /ID# 163792
Gothenburg, Västra Götaland County, 413 45
Duplicate_Sahlgrenska University Hospital /ID# 163797
Gothenburg, Västra Götaland County, 413 46
Skane University hospital /ID# 211745
Malmö, Skåne County, 214 28
Karolinska University Hospital Solna /ID# 212025
Solna, Stockholm County, 171 64
GHP Stockholm Gastro Center /ID# 211748
Stockholm, Stockholm County, 114 28
Medicinkliniken, Gastroenheten /ID# 163744
Stockholm, Stockholm County, 116 28
Danderyd Hospital /ID# 202138
Stockholm, Stockholm County, 182 88
Croatia6 sites
Poliklinika Borzan d.o.o. /ID# 157559
Osijek, County of Osijek-Baranja, 31000
Klinicki Bolnicki Centar Split /ID# 157562
Split, Split-Dalmatia County, 21000
Zadar General Hospital /ID# 157563
Zadar, 23000
Klinicka bolnica Dubrava Zagreb /ID# 157560
Zagreb, City of Zagreb, 10000
Klinicki bolnicki centar Sestre milosrdnice /ID# 157728
Zagreb, City of Zagreb, 10000
Klinicki bolnicki centar Zagreb /ID# 157561
Zagreb, City of Zagreb, 10000
Egypt6 sites
Zagazig University Hospitals /ID# 164539
Al Sharqia, 44519
Alexandria University /ID# 157187
Alexandria, Alexandria Governorate, 21131
Alexandria University /ID# 164540
Alexandria, Alexandria Governorate, 21131
Clinical Research Center, Faculty of Medicine, Cairo university /ID# 157175
Cairo, 11559
National Hepatology and Tropical Medicine Research Institute /ID# 157874
Cairo, 11559
Duplicate_Internal Medicine Department, Faculty of Medicine, AinShams University /ID# 157506
Cairo, 11566
Denmark5 sites
Aarhus Universitetshospital - Skejby /ID# 155664
Aarhus, Central Jutland, 8200
Kobenhavns Universitet - Hvidovre Hospital (HH) /ID# 155530
Hvidovre, Capital Region, 2650
Sygehusenheden Nyborg - OUH /ID# 161525
Nyborg, Region Syddanmark, 5800
Odense University Hospital /ID# 155531
Odense, Region Syddanmark, 5000
Roskilde Sygehus /ID# 155532
Roskilde, Region Sjælland, 4000
Taiwan5 sites
China Medical University Hospital /ID# 160141
Taichung, 40447
Taichung Veterans General Hospital /ID# 160140
Taichung, 40705
National Cheng Kung University Hospital /ID# 160142
Tainan, 704
National Taiwan University Hospital /ID# 162190
Taipei, 100
Taipei Veterans General Hosp /ID# 212712
Taipei, 11217
Argentina4 sites
Cemic /Id# 168078
Ciudad Autonoma Buenos Aires, Buenos Aires, 1431
Hospital Britanico de Buenos Aires /ID# 168077
Ciudad Autonoma de Buenos Aire, Buenos Aires, 1280
Hospital Privado Universitario - Hospital Privado Centro Medico de Cordoba S.A. /ID# 168076
Córdoba, 5016
Hospital Provincial del Centenario /ID# 170886
Rosario, Santa Fe Province, 2000
Australia4 sites
Emeritus Research /ID# 213512
Camberwell, Victoria, 3124
Lyell McEwin Hospital /ID# 212215
Elizabeth Vale, South Australia, 5112
Mater Misericordiae Limited /ID# 167220
South Brisbane, Queensland, 4101
Griffith University /ID# 212635
Southport, Queensland, 4222
Austria4 sites
Medizinische Universitaet Graz /ID# 158140
Graz, Styria, 8010
Universitaetsklinikum St. Poelten /ID# 166424
Sankt Pölten, Lower Austria, 3100
Krankenhaus der Barmherzigen Brueder Wien /ID# 212060
Vienna, State of Vienna, 1020
Medizinische Universitaet Wien /ID# 158141
Vienna, State of Vienna, 1090
Chile4 sites
Hospital Guillermo Grant Benavente de Concepción /ID# 210760
Concepción, Biobio, 4070038
Servicio de Salud Occidente Hospital San Juan de Dios /ID# 171122
Santiago, Region Metropolitana Santiago, 8350488
Complejo Asistencial Dr. Sotero del Rio /ID# 169384
Santiago, Santiago Metropolitan, 8207257
Hospital Las Higueras /ID# 167092
Talcahuano, Biobio, 1740000
Colombia4 sites
Hospital Univ San Ignacio /ID# 158734
Bogota, Cundinamarca, 110231
Instituto de Coloproctologia ICO - Medellin /ID# 158743
Medellín, Antioquia, 050024
Hospital Pablo Tobon Uribe /ID# 158730
Medellín, Antioquia, 050034
Hospital Universitario San Vic /ID# 171486
Medellín, Antioquia, 50010
Mexico4 sites
JM Research SC /ID# 170729
Cuernavaca, Morelos, 62290
Health Pharma Professional Research S.A de C.V /ID# 170730
Del. Benito Juárez, 03810
Unidad de Atencion Medica e Investigacion en Salud /ID# 170732
Mérida, Yucatán, 97000
Investigacion Biomedica para el Desarrollo de Farmacos, S.A. de C.V. /ID# 170734
Zapopan, Jalisco, 45070
New Zealand4 sites
Christchurch Hospital. /ID# 167224
Christchurch, Canterbury, 8011
Dunedin Hospital /ID# 167227
Otago, Otago, 9016
Aotearoa Clinical Trials /ID# 167226
Papatoetoe, Auckland, 2025
Duplicate_Wellington Hospital (Capital and Coast District Health Board) /ID# 167225
Wellington, 6021
Norway4 sites
Helse More og Romsdal HF, Alesund sjukehus /ID# 212810
Ålesund, Møre og Romsdal, 6017
Duplicate_Vestre viken - Baerum Sykehus /ID# 212996
Gjettum, Akershus, 1346
Sykehuset Levanger Helse NT /ID# 201669
Levanger, Nord-Trondelag, 7601
Akershus Universitetssykehus /ID# 169379
Nordbyhagen, Akershus, 1474
Romania4 sites
Fundeni Clinical Institute /ID# 170899
Bucharest, 022328
Tvm Med Serv Srl /Id# 170902
Cluj-Napoca, 400132
Cabinet Particular Policlinic Algomed /ID# 170900
Timișoara, 300002
Duplicate_Centrul Medical Tuculanu SRL /ID# 170903
Timișoara, 300168
South Africa4 sites
Private Practice Dr MN Rajabally /ID# 163112
Cape Town, Western Cape, 7800
Spoke Research Inc /ID# 158116
CAPE TOWN Milnerton, Western Cape, 7441
Clinresco Centers /ID# 163865
Johannesburg, Gauteng, 1619
Wits Clinical Research /ID# 158114
Johannesburg, Gauteng, 1864
Belarus3 sites
Gomel Regional Clinical Hospital /ID# 205112
Homyel, 246029
Grodno city clinical hospital #2 /ID# 205113
Hrodna, Grodnenskaya, 230011
Vitebsk Regional Advanced Clin /ID# 206778
Vitebsk, 210001
Estonia3 sites
North Estonia Medical Centre /ID# 164326
Mustamäe, Harju, 13419
West Tallinn Central Hospital /ID# 157075
Tallinn, Harju, 10617
East Tallinn Central Hospital /ID# 157074
Tallinn, 10138
Ireland3 sites
Duplicate_Beaumont Hospital /ID# 157543
Beaumont, Dublin, D09 XR63
St Vincents University Hospital /ID# 157540
Elm Park, Dublin, D04 T6F4
University Hospital Galway /ID# 157541
Galway, H91 YR71
Latvia3 sites
VCA Polyclinic Aura /ID# 159611
Riga, 1035
Pauls Stradins Clinical University Hospital /ID# 159612
Riga, LV-1002
Duplicate_Digestive Disease Center Gastro /ID# 163107
Riga, LV-1079
Malaysia3 sites
Queen Elizabeth Hospital /ID# 160664
Division Pantai Barat Utara, Sabah, 88200
Universiti Sains Malaysia /ID# 160666
Kelantan, Kelantan, 16150
Universiti Kebangsaan Malaysia (UKM) Medical Centre /ID# 201363
Kuala Lumpur, Selangor, 56000
Singapore3 sites
Mount Elizabeth Hospital /ID# 205741
Singapore, Central Singapore, 228510
National University Hospital /ID# 160667
Singapore, 119074
Singapore General Hospital /ID# 160668
Singapore, 169608
Slovakia3 sites
Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica /ID# 156468
Banská Bystrica, Banská Bystrica Region, 975 17
KM Management, spol. s.r.o. /ID# 206764
Nitra, Nitra Region, 949 01
Gastro I., s.r.o. /ID# 156469
Prešov, Presov, 080 01
Switzerland3 sites
University Hospital Basel /ID# 164554
Basel Town, Canton of Basel-City, 4031
Inselspital, Universitaetsspital Bern /ID# 163535
Bern, 3010
University Hospital Zurich /ID# 163536
Zurich, Canton of Zurich, 8091
Bosnia and Herzegovina2 sites
University Clinical Centre of the Republic of Srpska /ID# 164513
Banja Luka, Republika Srpska, 78000
Clinical Center University of Sarajevo /ID# 165139
Sarajevo, 71000
Hong Kong2 sites
Queen Mary Hospital /ID# 163923
Hong Kong, 999077
Tuen Mun Hospital /ID# 163905
Hong Kong
Lithuania2 sites
Hospital of Lithuanian University of Health Sciences Kaunas Clinics /ID# 162583
Kaunas, 50161
Vilnius University Hospital Santaros Klinikos /ID# 162514
Vilnius, 08661
Netherlands2 sites
Amsterdam University Medical Center /ID# 157956
Amsterdam, North Holland, 1105 AZ
Elisabeth Tweesteden Ziekenhuis /ID# 163632
Tilburg, North Brabant, 5022 GC
About this study
Official title: A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease
The study consists of 4 sub-studies, as follows:
- Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safety of risankizumab versus placebo as maintenance therapy in participants with moderately to severely active Crohn's disease (CD) who responded to intravenous risankizumab induction treatment in Study M16-006 or Study M15-991;
- Sub-study 2 (Randomized, exploratory maintenance study) to evaluate the efficacy and safety of two different dosing regimens for risankizumab as maintenance therapy in participants who responded to induction treatment in Study M16-006 or Study M15-991;
- Sub-study 3 (Open-label, long-term extension study) to evaluate long-term safety of risankizumab in participants who completed Sub-study 1, Sub-study 2, another AbbVie risankizumab Crohn's disease study, or participants who responded to induction treatment in Study M16-006 or Study M15-991 with no final endoscopy due to the Covid-19 pandemic. Additional objectives are to further investigate long-term efficacy and tolerability of risankizumab;
- Sub-study 4 (Open-label On Body Injector (OBI) administration and long-term extension study) to evaluate patient-reported outcomes, efficacy, safety, tolerability, and pharmacokinetics of risankizumab administered via OBI in participants who are receiving maintenance treatment with risankizumab.
- OL CTE to ensure uninterrupted care in accordance with local regulations until risankizumab is commercially available for participants who completed Sub-study 3, Sub-study 4.
- Conditions
- Crohn's Disease
- Being tested
- Placebo for Risankizumab SC, Risankizumab IV, Placebo for Risankizumab IV, Risankizumab SC, Risankizumab On-Body Injector (OBI)
- Keywords
- Risankizumab, ABBV-066, BI 655066, SKYRIZI, Crohn's Disease (CD)
- Medical subject headings
- Crohn Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Placebo for Risankizumab SCDrug
Placebo for Risankizumab SC Subcutaneous (SC) Injection
Risankizumab IVDrug
Also called ABBV-066, BI 655066, SKYRIZI
Risankizumab IV Intravenous (IV) infusion
Placebo for Risankizumab IVDrug
Placebo for Risankizumab IV Intravenous (IV) infusion
Risankizumab SCDrug
Also called ABBV-066, BI 655066, SKYRIZI
Risankizumab SC Subcutaneous (SC) injection
Risankizumab On-Body Injector (OBI)Drug
Also called ABBV-066, BI 655066, SKYRIZI
Subcutaneous (SC) injection; on-body injector (OBI)
| Study group | Role | What they receive |
|---|---|---|
| Double-blind Placebo for Risankizumab (Sub-Study 1) | Placebo comparator | Participants randomized to receive double-blind placebo for risankizumab for 52 weeks. Receives: Drug: Placebo for Risankizumab SC |
| Double-blind Risankizumab Dose 1 (Sub-Study 1) | Experimental | Participants randomized to receive double-blind risankizumab dose 1 for 52 weeks. Receives: Drug: Risankizumab SC |
| Double-blind Risankizumab Dose 2 (Sub-Study 1) | Experimental | Participants randomized to receive double-blind risankizumab dose 2 for 52 weeks. Receives: Drug: Risankizumab SC |
| Maintenance Risankizumab Dose 1 (Sub-Study 2) | Experimental | Participants will receive double-blind subcutaneous (SC)risankizumab dose 1 and intravenous placebo at Week 0 followed by open-label SC risankizumab dose 1 from Week 8 through Week 52. Receives: Drug: Placebo for Risankizumab IV; Drug: Risankizumab SC |
| Maintenance Risankizumab Dose 2 (Sub-Study 2) | Experimental | Participants will receive double-blind subcutaneous placebo and intravenous risankizumab dose 3 at Week 0 followed by open-label SC risankizumab dose 1 from Week 8 through Week 52. Receives: Drug: Placebo for Risankizumab SC; Drug: Risankizumab IV; Drug: Risankizumab SC |
| Open-label Risankizumab (Sub-Study 3) | Experimental | Participants who completed Sub-study 1 or Sub-study 2 or other AbbVie risankizumab Crohn's disease study or M16-006 or M15-991 without endoscopy will receive open-label risankizumab dose 1 or dose 2 depending on their preceding study beginning at Week 56. Receives: Drug: Risankizumab SC |
| Risankizumab On-Body Injector and Open Label (Sub-Study 4) | Experimental | Participants in Sub-study 3 who meet eligible criteria for Sub-study 4 will receive risankizumab dose 1 or dose 2 via on-body injectors on Weeks 0,8 and 16. Beginning Week 24, participants will receive risankizumab dose 1 or dose 2 via pre-filled syringes Q8W. Receives: Drug: Risankizumab SC; Drug: Risankizumab On-Body Injector (OBI) |
| CTE: Open Label Continuous Treatment Extension | Experimental | Participants who tolerate and derive benefit from receiving risankizumab and complete Sub-study 3 or Sub-study 4 will receive risankizumab dose 1 or dose 2 Q8W. Receives: Drug: Risankizumab SC |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sub-Study 1: Percentage of Participants With Crohn's Disease Activity Index (CDAI) Clinical Remission
The CDAI is used to evaluate disease activity in patients with Crohn's disease. The CDAI clinical remission is defined as a CDAI score of < 150.
Measured: Week 52
Sub-Study 1: Percentage of Participants With Endoscopic Response
Endoscopic response defined as decrease from Baseline of the induction study in Simple Endoscopic Score for Crohn's Disease (SES-CD).
Measured: Week 52
Sub-Study 3: Number of Participants With Adverse Events
An adverse event (AE) is defined as any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. The investigator assessed the relationship of each event to the use of study drug as either probably related, possibly related, probably not related or not related. A serious adverse event (SAE) is an event that results in death, is life-threatening, requires or prolongs hospitalization, results in a congenital anomaly, persistent or significant disability/incapacity or is an important medical event that, based on medical judgment, may jeopardize the subject and may require medical or surgical intervention to prevent any of the outcomes listed above. Treatment-emergent AEs are defined as any event that began or worsened in severity after the first dose of study drug. For more details on adverse events please see the Adverse Event section.
Measured: Up to Week 220
Sub-Study 4: Percentage of Participants With an Observer Rating of Successful Participant Self Administration
Participant who successfully completed the sequence of critical steps in the instructions for use (IFU) without errors to administer study drug via the OBI at Week 0 and 16.
Measured: Up to Week 16
Sub-Study 4: Percentage of Participants who had no Potential Hazards
Measured by an observer on the possible use-related hazards checklist for self-administration with OBI at Week 0 and Week 16.
Measured: Up to Week 16
Sub-Study 4: Percentage of Participants Rating of Acceptability Using Self-Injection Assessment Questionnaire (SIAQ) at Weeks 0, 8, 16
SIAQ evaluations consist of the PRE module, which is self-completed immediately before the first OBI self-injection at baseline, and the POST module, which is self-completed 20 to 40 min following injections at Weeks 0, 8, 16. These modules are completed by participants while alone in a quiet environment.
Participants rate each item of the SIAQ. The ratings are later transformed to scores ranging from 0 (worst experience) to 10 (best experience). The domain score is the mean of the item scores included in the domain. Domain scores are calculated only if at least half of the domain items are completed. Item and domain scores from the PRE module are compared with the corresponding item and domain scores from the POST modules.
Measured: Up to Week 16
Sub-Study 4: Percentage of Participants in CDAI Clinical Remission at Week 0, 16
Clinical remission per average daily stool frequency (SF) and average daily abdominal pain (AP) score.
Measured: Up to Week 16
Secondary outcomes (12)
Sub-Study 1: Percentage of Participants With Clinical Remission
Clinical remission per average daily stool frequency (SF) and average daily AP score.
Measured: Week 52
Sub-Study 1: Percentage of Participants With CDAI Clinical Remission Among Participants With CDAI Clinical Remission in Week 0
The CDAI is used to evaluate disease activity in patients with Crohn's disease
Measured: Week 52
Sub-Study 1: Percentage of Participants With Ulcer-Free Endoscopy
Endoscopic healing was assessed using SES-CD.
Measured: Week 52
Sub-Study 1: Percentage of Participants With Endoscopic Remission
Endoscopic Remission is defined as SES-CD <= 4 and at least a 2 point reduction versus baseline and no subscore greater than 1 in any individual variable, as scored by a central reviewer
Measured: Week 52
Sub-Study 1: Change From Baseline of Induction in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue)
The FACIT-Fatigue is a validated tool that measures an individual's level of fatigue during their usual daily activities over the past week.
Measured: Week 52
Sub-Study 1: Percentage of Participants Who Discontinued Corticosteroid Use for 90 Days and Achieved Clinical Remission in Participants Taking Steroids at Baseline
Participants who discontinued corticosteroid use and achieved clinical remission per average daily SF and average daily AP score.
Measured: Week 52
Sub-Study 1: Percentage of Participants With Crohn's Disease Activity Index (CDAI) Clinical Response
The CDAI is used to evaluate disease activity in patients with Crohn's disease.
Measured: Week 52
Sub-Study 1: Percentage of Participants With Stool Frequency (SF) Remission
SF Remission is defined by an average daily SF <= 2.8 and not worse than baseline.
Measured: Week 52
Sub-Study 1: Percentage of Participants With Abdominal Pain (AP) Remission
AP Remission is defined by an average daily AP <= 1 and not worse than baseline.
Measured: Week 52
Sub-Study 1: Percentage of Participants With CDAI Clinical Remission and Endoscopic Response
The CDAI is used to evaluate disease activity in patients with Crohn's disease. The CDAI clinical remission is defined as a CDAI score of < 150. Endoscopic response defined as decrease from baseline of > 50% of the induction study in Simple Endoscopic Score for Crohn's Disease (SES-CD).
Measured: Week 52
Sub-Study 1: Percentage of Participants With Deep Remission
Deep remission defined as participants with both clinical remission (per average daily SF and average daily AP score) and endoscopic remission (assessed using SES-CD).
Measured: Week 52
Sub-Study 1: Percentage of Participants With Exposure Adjusted Occurrence of CD-related Hospitalizations From Week 0 Through Week 52
Participants with an event that results in admission to the hospital.
Measured: Up to Week 52
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Apr 2017
- Study start9 Apr 2018
- Primary completionFeb 2029 (estimated)
- Study completionFeb 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for Crohn's DiseaseStudies of the same condition, open and under way.
- More trials run by AbbVieThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 1,336 participants (actual)
Sponsor and investigators
- Lead sponsor
- AbbVie
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- ABBVIE INC., Study director, AbbVie
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03105102
- Sponsor's protocol ID
- M16-000
- Other IDs
- 2023-506399-28-00, 2023
- Acronym
- FORTIFY
- Status last verified
- Aug 2026
- First submitted
- 4 Apr 2017
- Last updated
- 14 Aug 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- Yes: AbbVie is committed to responsible clinical trial data sharing. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information.
- Expanded access
- Available
Publications
Panaccione R, Ferrante M, Dotan I, Panes J, Hisamatsu T, Bossuyt P, Danese S, Song A, Kalabic J, Joshi N, Zambrano J, Zhang Y, Duan WR, Kligys K, Dubinsky MC, Lindsay JO, Vermeire S, Siegmund B, Irving PM, D'Haens G. Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment. Clin Gastroenterol Hepatol. 2025 Oct;23(11):2012-2022.e6. doi: 10.1016/j.cgh.2024.12.023. Epub 2025 Feb 3.
PubMed 39909280Feagan BG, Colombel JF, Panaccione R, Schreiber S, Ferrante M, Kamikozuru K, Ma C, Lee WJ, Griffith J, Joshi N, Kligys K, Kalabic J, Xuan S, Dubinsky M. Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn's Disease. Gastro Hep Adv. 2024 Sep 5;4(1):100544. doi: 10.1016/j.gastha.2024.08.022. eCollection 2025.
PubMed 39802486Atreya R, Ferrante M, Panaccione R, Feagan B, Shchukina O, Jairath V, Rieder F, Hisamatsu T, Siegmund B, Kligys K, Song A, Zambrano J, Mallick M, Zhang Y, Armuzzi A, D'Haens G. Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies. J Crohns Colitis. 2025 Apr 4;19(4):jjae164. doi: 10.1093/ecco-jcc/jjae164.
PubMed 39485390Peyrin-Biroulet L, Colombel JF, Louis E, Ferrante M, Motoya S, Panaccione R, Torres J, Ungaro RC, Kligys K, Kalabic J, Zambrano J, Zhang Y, D'Haens G. Shorter Crohn's Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies. Gastro Hep Adv. 2024 Mar 7;3(4):539-550. doi: 10.1016/j.gastha.2024.02.008. eCollection 2024.
PubMed 39131711Schreiber S, Cross RK, Panaccione R, D'Haens G, Bossuyt P, Dotan I, Colombel JF, Louis E, Dubinsky MC, Kligys K, Neimark E, Song A, Zambrano J, Kalabic J, Cheng E, Zhang Y, Ferrante M. Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease. Aliment Pharmacol Ther. 2024 Oct;60(7):897-906. doi: 10.1111/apt.18184. Epub 2024 Jul 25.
PubMed 39054592Ferrante M, Irving PM, Abreu MT, Axler J, Gao X, Cao Q, Fujii T, Rausch A, Torres J, Neimark E, Song A, Wallace K, Kligys K, Berg S, Liao X, Zhou Q, Kalabic J, Feagan B, Panaccione R. Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial. J Crohns Colitis. 2024 Mar 1;18(3):416-423. doi: 10.1093/ecco-jcc/jjad168.
PubMed 37797293Dubinsky M, Ma C, Griffith J, Crowell M, Neimark E, Kligys K, O'Connell T. Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn's Disease. Adv Ther. 2023 Sep;40(9):3896-3911. doi: 10.1007/s12325-023-02546-6. Epub 2023 Jun 27.
PubMed 37368103Loftus EV Jr, Griffith J, Neimark E, Song A, Wallace K, Nannapaneni S, Zhou J, Byrne R, Kligys K, Pang Y, Liao X, Kalabic J, Dubinsky M. Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn's Disease. Adv Ther. 2023 May;40(5):2311-2325. doi: 10.1007/s12325-023-02477-2. Epub 2023 Mar 14.
PubMed 36917429Ferrante M, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV Jr, Panes J, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, D'Haens G. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial. Lancet. 2022 May 28;399(10340):2031-2046. doi: 10.1016/S0140-6736(22)00466-4.
PubMed 35644155